Massachusetts Financial Services Co. MA Sells 2,506,071 Shares of Bruker Co. (NASDAQ:BRKR)

Massachusetts Financial Services Co. MA lowered its holdings in Bruker Co. (NASDAQ:BRKR - Free Report) by 45.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,952,303 shares of the medical research company's stock after selling 2,506,071 shares during the period. Massachusetts Financial Services Co. MA owned approximately 1.95% of Bruker worth $173,064,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Eagle Bay Advisors LLC grew its position in Bruker by 2,324.1% during the fourth quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company's stock worth $41,000 after buying an additional 674 shares in the last quarter. UMB Bank n.a. increased its position in shares of Bruker by 37.5% in the fourth quarter. UMB Bank n.a. now owns 909 shares of the medical research company's stock worth $53,000 after purchasing an additional 248 shares during the period. GAMMA Investing LLC raised its stake in Bruker by 47.5% in the fourth quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company's stock valued at $75,000 after purchasing an additional 412 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in Bruker by 41.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 1,330 shares of the medical research company's stock worth $78,000 after purchasing an additional 390 shares during the period. Finally, Blue Trust Inc. grew its stake in Bruker by 13.5% during the fourth quarter. Blue Trust Inc. now owns 2,164 shares of the medical research company's stock worth $127,000 after buying an additional 257 shares in the last quarter. Institutional investors and hedge funds own 79.52% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on BRKR. Guggenheim reaffirmed a "buy" rating on shares of Bruker in a report on Monday, February 24th. Stifel Nicolaus reduced their target price on Bruker from $70.00 to $57.00 and set a "hold" rating on the stock in a report on Friday, February 14th. Citigroup lowered their price target on Bruker from $75.00 to $50.00 and set a "buy" rating for the company in a report on Monday. Barclays reduced their price objective on Bruker from $69.00 to $65.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Finally, UBS Group started coverage on Bruker in a research note on Tuesday, December 10th. They set a "neutral" rating and a $66.00 target price for the company. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $68.00.

Bruker Trading Up 13.3 %

NASDAQ BRKR traded up $4.83 on Wednesday, hitting $41.19. The company's stock had a trading volume of 5,029,560 shares, compared to its average volume of 1,444,719. The company's 50-day moving average is $46.89 and its 200 day moving average is $55.16. The firm has a market cap of $6.25 billion, a PE ratio of 54.20, a PEG ratio of 2.16 and a beta of 1.18. Bruker Co. has a 1-year low of $34.10 and a 1-year high of $90.56. The company has a quick ratio of 0.77, a current ratio of 1.60 and a debt-to-equity ratio of 1.15.

Bruker (NASDAQ:BRKR - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The medical research company reported $0.76 earnings per share for the quarter, beating analysts' consensus estimates of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. As a group, analysts predict that Bruker Co. will post 2.69 earnings per share for the current fiscal year.

Bruker Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 28th. Investors of record on Monday, March 17th were issued a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.49%. The ex-dividend date of this dividend was Monday, March 17th. Bruker's payout ratio is presently 26.32%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.